Original ArticleLocal Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer
Under an Elsevier user license
open archive
Key Words
EGFR-mutant non–small-cell lung cancer
anaplastic lymphoma kinase gene arrangement non–small-cell lung cancer
Radiation therapy
Oligoprogressive disease
Cited by (0)
Disclosure: Drs. Weickhardt, Doeble, and Camidge have received speaking honoraria from Pfizer. The other authors declare no conflicts of interest.
Copyright © 2012 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.